Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $554,079 - $947,768
486,035 Added 227.16%
700,000 $1.3 Million
Q3 2022

Nov 14, 2022

SELL
$0.73 - $3.74 $260,581 - $1.34 Million
-356,961 Reduced 62.52%
213,965 $668,000
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $951,744 - $1.82 Million
432,611 Added 312.77%
570,926 $1.36 Million
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $391,431 - $1.2 Million
138,315 New
138,315 $557,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Autonomy Capital (Jersey) L.P. Portfolio

Follow Autonomy Capital (Jersey) L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Autonomy Capital (Jersey) L.P., based on Form 13F filings with the SEC.

News

Stay updated on Autonomy Capital (Jersey) L.P. with notifications on news.